Since its initial identification [7], fibroblast growth factor 21 (FGF21) has been shown to be a key hormonal regulator of glucose metabolism and energy balance [8–11], representing a promising potential approach for the treatment of obesity and T2DM. The gene discussed is FGF21; the disease is obesity disorder.